2021 American Transplant Congress
Renal Transplant is Safe in Septuagenarians
Abdominal Transplant Surgery, University of North Carolina at Chapel Hill, Chapel Hill, NC
*Purpose: With increasing life expectancy, there has been increase in transplant rates amongst elderly recipients who often have more comorbidities than younger recipient. The aim…2021 American Transplant Congress
The Impact of Fixed-Dose Alemtuzumab in Renal Transplant Recipients According to Weight
*Purpose: Alemtuzumab, a potent anti-CD52 monoclonal antibody is used for induction immunosuppression post-renal transplantation as a fixed 30mg dose regardless of the patient’s weight. The…2021 American Transplant Congress
Belatacept Utilization During the Covid-19 Pandemic in the United States
*Purpose: With the onset of the COVID-19 pandemic, many people in the United States were urged to stay at home. Kidney transplantation continued during this…2021 American Transplant Congress
Patient Survival After Living Donor Kidney Donation
*Purpose: Living donor kidney transplantation [LDKT] is associated with best patient survival and life quality among kidney replacement therapies in case of chronic kidney disease.…2021 American Transplant Congress
Kidney Transplant Associated Allergy Transfer After Living Donation
*Purpose: Donor to recipient IgE-mediated food allergy transfer has been described in non-kidney solid organ transplant. Here, we report a novel case of an adult…2021 American Transplant Congress
Robotic Assisted Donor Nephrectomy: A Single Center Experience
Transplant Surgery, Virginia Commonwealth University, Richmond, VA
*Purpose: Robotic donor nephrectomy (RLDN) is an emerging procedure of choice for living kidney donors at many programs. This approach has benefit of minimal invasive…2021 American Transplant Congress
Pediatric Kidney Transplant Strategy: The Sequence Effect
*Purpose: Improvements in patient survival with pediatric end stage kidney disease (ESKD) predicts needing more than one kidney transplant over a child’s lifetime. Timing of…2021 American Transplant Congress
Single Center Experience on SARS-CoV-2 Testing of Symptomatic and Asymptomatic Pediatric Kidney Transplant Recipients
*Purpose: As of late November 2020, there have been 61.5 million cases of SARS-CoV-2 (COVID-19) worldwide resulting in 1.44 million deaths. Despite the outstanding number…2021 American Transplant Congress
Graft Outcomes of Antibody Mediated Rejection without Donor Specific Anti – HLA Antibodies After Kidney Transplantation
Seoul National University Hospital, Seoul, Korea, Republic of
*Purpose: The aim of this study was to investigate graft outcomes based on the presence of donor-specific anti-HLA antibodies (DSA) and the time of diagnosis…2021 American Transplant Congress
Clazakizumab for the Treatment of Chronic Active Antibody-Mediated Rejection in Kidney Transplant Recipients: Phase 3 IMAGINE Study Design
*Purpose: Chronic active antibody-mediated rejection (CAMR) is a major cause of allograft loss with no approved drugs for its treatment. Currently, off-label regimens recommended by…
American Transplant Congress abstracts